MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-24-0034816
Savorite Pharmaceuticals Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹113.71 Cr
▼ 12% YoY
Net profit · FY 2025
₹6.33 Cr
Net margin 5.6%
EBITDA · FY 2025
₹11.1 Cr
EBITDA margin 9.8%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹51 Lakh
Issued & subscribed
Open charges
₹9.25 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
4
Provident fund records
About Savorite Pharmaceuticals Private Limited
Data last updated:
Savorite Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33125GJ2019PTC105923. Its GSTIN is 24ABBCS3795F1Z9 (Gujarat).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹51 Lakh. It is led by directors Nandkishore Maheshwari and Vedant Nandkishore Maheshwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 703 Atlantis Hights Vadiwadi Sarabhai Compound Village: Vadodara, Gujarat, India – 390007.
As per the financials filed for FY 2025, the company reported a revenue of ₹113.71 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹6.33 Cr (net margin 5.6%) and EBITDA of ₹11.1 Cr (EBITDA margin 9.8%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years.
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Savorite Pharma. As per MCA filings, the company has open charges of ₹9.25 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 4 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹50 Lakh; the latest was in February 2022. Its 8 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Pharose Remedies Limited with revenue of ₹115.39 Cr.
Savorite Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0034816). For more details, the company can be reached via its website savoritepharma.com.
Company details
CIN U33125GJ2019PTC105923
Registration Number 105923
Incorporation Date 07 January 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-GJ-24-0034816
Recognitions & Rankings of Savorite Pharmaceuticals
Contact details
Savorite Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is savoritepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address703 Atlantis Hights Vadiwadi Sarabhai Compound Village: Vadodara, Gujarat, India – 390007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Savorite Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Savorite Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Savorite Pharmaceuticals operates one associated brand: Savorite Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical formulations from India. | savoritepharma.com |
Business activity
The main business activity of Savorite Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Savorite Pharmaceuticals Private Limited, buy the company report.
Financials of Savorite Pharmaceuticals Private Limited
FY 2025 filings availableSavorite Pharmaceuticals Private Limited reported revenue of ₹113.71 Cr (down 12% YoY) for FY 2025.
Revenue · FY 2025
₹113.71 Cr ▼ 12%
Net profit · FY 2025
₹6.33 Cr margin 5.6%
EBITDA · FY 2025
₹11.1 Cr margin 9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 46%
EBITDA CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 49%
5 years · compounded
▲ 267%
Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 46%. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.1 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.33 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Savorite Pharmaceuticals Private Limited, buy the company report.
Board of directors of Savorite Pharmaceuticals Private Limited
Savorite Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandkishore Maheshwari Also directs: Mypher Pharmaceuticals LLP, Aviance Pharmaceuticals Private Limited, Avoure Pharma & Healthcare Private Limited and 1 more | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
| Vedant Nandkishore Maheshwari Also directs: Mypher Pharmaceuticals LLP, Aviance Pharmaceuticals Private Limited, Avoure Pharma & Healthcare Private Limited and 2 more | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Savorite Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharose Remedies Limited | ₹115.39 Cr (FY 2025) | 4.0% | Punjab, India | |||
| Biogenetic Drugs Private Limited | ₹115.34 Cr (FY 2025) | -2.0% | Jaipur, Rajasthan, India | |||
| Synthokem Labs Private Limited | ₹113.98 Cr (FY 2024) | 2.0% | Patancheru, Telangana, India | |||
| Savorite Pharmaceuticals Private Limitedthis company | ₹113.71 Cr (FY 2025) | ₹6.33 Cr | 5.6% | -12.0% | 4 | Vadodara, Gujarat, India |
| Socomed Pharma Private Limited | ₹113.64 Cr (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Seagull Pharmaceuticals Pvt Ltd | ₹113.36 Cr (FY 2025) | 8.0% | Naraina Vihar, Delhi, India | |||
| Stadmed Pvt Ltd | ₹112.88 Cr (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Shree Ganesh Remedies Limited | ₹112.33 Cr (FY 2025) | -13.0% | Anklesvar, Gujarat, India | |||
| Unicure Remedies Private Limited | ₹112.25 Cr (FY 2025) | -13.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Savorite Pharmaceuticals Private Limited, buy the company report.
Auditor
Savorite Pharmaceuticals Private Limited is audited by Akshay Shah & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Akshay Shah & Co. | FY 2023 | 100268W |
Shareholding
The shareholding of Savorite Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Savorite Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.25 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Feb 2022 | 100566150 | Axis Bank Limited | ₹9.25 Cr | Open |
To see the full charge records of Savorite Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Savorite Pharmaceuticals Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹50 Lakh; the latest was in February 2022.
Total deals
1
Funding round
1
Disclosed funding
₹50 Lakh
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2022 | Funding round | ₹50 Lakh | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Savorite Pharmaceuticals Private Limited has 5 court cases on record: 2 filed by Savorite Pharmaceuticals, 3 filed against it. 4 cases are pending and 1 is disposed.
Total cases
5
Filed by the company
2
Filed against the company
3
Pending
4
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 2 |
| District courts | 2 | 0 | 2 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Commercial matter | Filed by the company against Ami Global Logistics Private Limited | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Shalina Laboratories Private Limited and Anr and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
| District court, Vadodara, Gujarat | Court case (SMST S) | Filed by the company against an individual | Pending |
To see the full case history of Savorite Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Savorite Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Savorite Pharmaceuticals Private Limited has a workforce of 4 employees on its EPFO records as of Oct 10, 2025, across 1 active EPFO establishment.
Employee count
4
Active EPFO establishments
1
Employee growth
-20%
GST
Savorite Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ABBCS3795F1Z9 | Gujarat | Active | 27 Mar 2019 |
To see the full GST registrations and return filing status of Savorite Pharmaceuticals Private Limited, buy the company report.
Recent activity
Savorite Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Nandkishore Maheshwari was appointed as Director on 07 Jan 2019.
Charges
A charge with Axis Bank Limited of Rs. 9.25 Cr registered on 22 Feb 2022 with Charge ID 100566150 was modified on 03 Nov 2025.
AGM
Savorite Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Savorite Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 9.25 Cr with Charge ID 100566150 was registered on 22 Feb 2022.
Appointed
Nandkishore Maheshwari was appointed as Director.
Appointed
Vedant Nandkishore Maheshwari was appointed as Director.
Incorporation
07 Jan 2019
Savorite Pharmaceuticals Private Limited was registered on 07 Jan 2019 with Roc Ahmedabad & aged 7 years 9 months as per MCA records.
Frequently asked questions
Savorite Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 January 2019 (7+ years old) and is registered under CIN U33125GJ2019PTC105923.
Savorite Pharmaceuticals has 2 current directors:
- Nandkishore Maheshwari - Director
- Vedant Nandkishore Maheshwari - Director
The latest financial statements of Savorite Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Savorite Pharmaceuticals is 24ABBCS3795F1Z9, registered in Gujarat.
The CIN (Corporate Identification Number) of Savorite Pharmaceuticals is U33125GJ2019PTC105923. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Savorite Pharmaceuticals has 5 court cases on record: 2 filed by the company and 3 filed against it. 4 are pending. Most are in the high courts.
Savorite Pharmaceuticals was incorporated on 07 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Savorite Pharmaceuticals has 1 deal on record (1 funding round), with disclosed funding of ₹50 Lakh; the latest was in February 2022.
The peers of Savorite Pharmaceuticals by revenue are Pharose Remedies Limited, Biogenetic Drugs Private Limited, Synthokem Labs Private Limited, Socomed Pharma Private Limited, Seagull Pharmaceuticals Pvt Ltd and 3 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nandkishore Maheshwari was appointed as Director on 07 Jan 2019. Vedant Nandkishore Maheshwari was appointed as Director on 07 Jan 2019.
Yes, Savorite Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-GJ-24-0034816).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages